Бизнес · 31.03.19941 мин чтения
Solvay Pharmaceuticals et al.; Withdrawal of Approval of 24 Abbreviated New Drug Applications
Локальный автоматический перевод · Язык оригинального источника
Краткое содержание
The Food and Drug Administration (FDA) is withdrawing approval of 24 abbreviated new drug applications (ANDA's). The holders of the ANDA's notified the agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.